Table 1.

Patient characteristics and treatment outcome

Characteristics	Mean (%)
Gleason score
5	7/32 (21.8)
6	11/32 (34.4)
7	14/32 (43.7)
Pathological stage
T1	15/32 (46.9)
T2	17/32 (53.1)
	Average (min–max)
Preoperative PSA (ng/mL)	8.64 (4.5–12.0)
Mean IPSS	12.13 (8–20)
Prostate volume (mL)	52.6 (42.7–65.0)
Age (years)
Control	56 (39–68)
PCa	69 (48–83)

Abbreviations: IPSS, International Prostate Symptom Score; PCa, prostate cancer; PSA, prostate-specific antigen.